Xiaojing Chi
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
-
- Cancer-related molecular mechanisms research
Papers in
- Virology 5
- HIV Research and Treatment 4
-
- Hepatitis C virus research 7
- Co-authors
- Wei YangXiuying LiuJingjing FanYuqiang NiuMin ChengXinhui ZhangLili RenJianwei Wang
- Journals
- Journal of Virology (4 papers)Frontiers in Immunology (3 papers)Antiviral Research (3 papers)PLoS ONE (3 papers)Journal of Medical Virology (2 papers)
- Partner nations
- ChinaIndonesiaUnited States
In The Last Decade
Xiaojing Chi
30 papers receiving 579 citations
Peers
Comparison fields: 5 of 76
- Infectious Diseases 163
- Cancer Research 112
- Hepatology 55
- Immunology 122
- Virology 25
Countries citing papers authored by Xiaojing Chi
This map shows the geographic impact of Xiaojing Chi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojing Chi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojing Chi more than expected).
Fields of papers citing papers by Xiaojing Chi
This network shows the impact of papers produced by Xiaojing Chi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojing Chi. The network helps show where Xiaojing Chi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojing Chi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 39 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 103 | |
| 10 | 2019 | 43 | |
| 11 | 2018 | 10 | |
| 12 | 2018 | 10 | |
| 13 | 2017 | 5 | |
| 14 | 2017 | 79 | |
| 15 | 2017 | 8 | |
| 16 | 2016 | 11 | |
| 17 | 2016 | 7 | |
| 18 | 2014 | 4 | |
| 19 | 2013 | 6 | |
| 20 | 2011 | 9 |
About Xiaojing Chi
Xiaojing Chi is a scholar working on Virology, Hepatology, Immunology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 584 indexed citations. Recurring topics across this work include interferon and immune responses (7 papers), Hepatitis C virus research (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers), HIV Research and Treatment (4 papers), Herpesvirus Infections and Treatments (4 papers), Hepatitis B Virus Studies (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virology and Viral Diseases (3 papers). The work is most often cited by research in Infectious Diseases (163 citations), Cancer Research (112 citations), Hepatology (55 citations), Immunology (122 citations) and Virology (25 citations). Xiaojing Chi has collaborated with scholars based in China, Indonesia and United States. Frequent co-authors include Wei Yang, Xiuying Liu, Jingjing Fan, Yuqiang Niu, Min Cheng, Xinhui Zhang, Lili Ren, Jianwei Wang, Jin Zhong and Qi Jin. Their work appears in journals such as Journal of Virology, Frontiers in Immunology, Antiviral Research, PLoS ONE and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.